Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 389

1.

Safety of non-steroidal anti-inflammatory drugs in the postpartum period among women with hypertensive disorders of pregnancy: a meta-analysis.

Bellos I, Pergialiotis V, Antsaklis A, Loutradis D, Daskalakis G.

Ultrasound Obstet Gynecol. 2020 Feb 18. doi: 10.1002/uog.21997. [Epub ahead of print] Review.

PMID:
32068930
2.

Organochlorine pollutants' levels in hair, amniotic fluid and serum samples of pregnant women in Greece. A cohort study.

Barmpas M, Vakonaki E, Tzatzarakis M, Sifakis S, Alegakis A, Grigoriadis T, Sodré DB, Daskalakis G, Antsaklis A, Tsatsakis A.

Environ Toxicol Pharmacol. 2020 Jan;73:103279. doi: 10.1016/j.etap.2019.103279. Epub 2019 Oct 16.

PMID:
31704585
3.

Evaluation of the efficacy of cervical pessary combined with vaginal progesterone in women with a short cervix and additional risk factors for preterm delivery.

Daskalakis G, Zacharakis D, Pergialiotis V, Kalmantis K, Theodora M, Siristatidis C, Antsaklis P, Antsaklis A, Loutradis D.

J Matern Fetal Neonatal Med. 2019 Jul 3:1-7. doi: 10.1080/14767058.2019.1634686. [Epub ahead of print]

PMID:
31216905
4.

Preterm Labor: Up to Date.

Daskalakis G, Arabin B, Antsaklis A, Cabero Roura L.

Biomed Res Int. 2019 May 9;2019:4870938. doi: 10.1155/2019/4870938. eCollection 2019. No abstract available.

5.

Progestogens for the prevention of preterm birth and risk of developing gestational diabetes mellitus: a meta-analysis.

Pergialiotis V, Bellos I, Hatziagelaki E, Antsaklis A, Loutradis D, Daskalakis G.

Am J Obstet Gynecol. 2019 Nov;221(5):429-436.e5. doi: 10.1016/j.ajog.2019.05.033. Epub 2019 May 24. Review.

PMID:
31132340
6.

Prevention of spontaneous preterm birth.

Daskalakis G, Goya M, Pergialiotis V, Cabero L, Kyvernitakis I, Antsaklis A, Arabin B.

Arch Gynecol Obstet. 2019 May;299(5):1261-1273. doi: 10.1007/s00404-019-05095-y. Epub 2019 Feb 14.

PMID:
30761417
7.

A stepwise approach for the management of short cervix: time to evolve beyond progesterone treatment in the presence of progressive cervical shortening.

Daskalakis G, Loutradis D, Antsaklis A, Pergialiotis V.

Am J Obstet Gynecol. 2019 Apr;220(4):404-405. doi: 10.1016/j.ajog.2019.01.221. Epub 2019 Jan 25. No abstract available.

PMID:
30690016
8.

Assessment of Uterocervical Angle Width as a Predictive Factor of Preterm Birth: A Systematic Review of the Literature.

Daskalakis G, Theodora M, Antsaklis P, Sindos M, Grigoriadis T, Antsaklis A, Papantoniou N, Loutradis D, Pergialiotis V.

Biomed Res Int. 2018 Dec 26;2018:1837478. doi: 10.1155/2018/1837478. eCollection 2018.

9.

Reply to: Cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth: is evidence sufficient?

Daskalakis G, Zacharakis D, Theodora M, Antsaklis P, Papantoniou N, Loutradis D, Antsaklis A.

J Perinat Med. 2018 Aug 28;46(6):693-694. doi: 10.1515/jpm-2018-0087. No abstract available.

PMID:
29672275
10.

Safety and efficacy of the cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth.

Daskalakis G, Zacharakis D, Theodora M, Antsaklis P, Papantoniou N, Loutradis D, Antsaklis A.

J Perinat Med. 2018 Jul 26;46(5):531-537. doi: 10.1515/jpm-2017-0009.

PMID:
29055173
11.

Subserosal uterine injection of blue dye for the identification of the sentinel node in patients with endometrial cancer: a feasibility study.

Biliatis I, Thomakos N, Koutroumpa I, Haidopoulos D, Sotiropoulou M, Antsaklis A, Vlachos G, Akrivos N, Rodolakis A.

Arch Gynecol Obstet. 2017 Sep;296(3):565-570. doi: 10.1007/s00404-017-4468-8. Epub 2017 Jul 25.

PMID:
28744616
12.

mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix.

Asimomytis A, Karanikou M, Rodolakis A, Vaiopoulou A, Tsetsa P, Creatsas G, Stefos T, Antsaklis A, Patsouris E, Rassidakis GZ.

Oncol Lett. 2016 Nov;12(5):3234-3240. Epub 2016 Aug 29.

13.

Laparoscopic Cystectomy In-a-Bag of an Intact Cyst: Is It Feasible and Spillage-Free After All?

Detorakis S, Vlachos D, Athanasiou S, Grigoriadis T, Domali A, Chatzipapas I, Stamatakis E, Mousiolis A, Patrikios A, Antsaklis A, Loutradis D, Protopapas A.

Minim Invasive Surg. 2016;2016:8640871. doi: 10.1155/2016/8640871. Epub 2016 Mar 23.

14.

Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C.

Onco Targets Ther. 2015 Jul 23;8:1843-7. doi: 10.2147/OTT.S78254. eCollection 2015.

15.

Fetal loss following second trimester amniocentesis. Who is at greater risk? How to counsel pregnant women?

Theodora M, Antsaklis A, Antsaklis P, Blanas K, Daskalakis G, Sindos M, Mesogitis S, Papantoniou N.

J Matern Fetal Neonatal Med. 2016;29(4):590-5. doi: 10.3109/14767058.2015.1012061. Epub 2015 Mar 9.

PMID:
25747948
16.

Risk for fetal loss and prematurity after 12,413 second trimester amniocenteses in a single center.

Theodora M, Antsaklis A, Blanas K, Antsaklis P, Daskalakis G, Sindos M, Mesogitis S, Papantoniou N.

J Perinat Med. 2015 May;43(3):347-51. doi: 10.1515/jpm-2014-0236.

PMID:
25485612
17.

Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.

Korompelis P, Piperi C, Adamopoulos C, Dalagiorgou G, Korkolopoulou P, Sepsa A, Antsaklis A, Papavassiliou AG.

Clin Chem Lab Med. 2015 Aug;53(9):1415-24. doi: 10.1515/cclm-2014-0798.

PMID:
25470608
18.

Agenesis of ductus venosus in sequential first and second trimester screening.

Iliescu DG, Cara ML, Tudorache S, Antsaklis P, Novac LV, Antsaklis A, Cernea N.

Prenat Diagn. 2014 Nov;34(11):1099-105. doi: 10.1002/pd.4434. Epub 2014 Jul 31.

PMID:
24931552
19.

IGF2BP1 expression in human mesenchymal stem cells significantly affects their proliferation and is under the epigenetic control of TET1/2 demethylases.

Mahaira LG, Katsara O, Pappou E, Iliopoulou EG, Fortis S, Antsaklis A, Fotinopoulos P, Baxevanis CN, Papamichail M, Perez SA.

Stem Cells Dev. 2014 Oct 15;23(20):2501-12. doi: 10.1089/scd.2013.0604. Epub 2014 Jul 14.

PMID:
24915579
20.

Gynecologic oncology patients in the surgical high dependency unit: an analysis of indications.

Thomakos N, Zacharakis D, Rodolakis A, Zagouri F, Papadimitriou CA, Bamias A, Dimopoulos MA, Haidopoulos D, Vlahos G, Antsaklis A.

Arch Gynecol Obstet. 2014 Aug;290(2):335-9. doi: 10.1007/s00404-014-3180-1. Epub 2014 Mar 18.

PMID:
24639289
21.

Posterior Deep Infiltrating Endometriotic Nodules: Operative Considerations according to Lesion Size, Location, and Geometry, during One's Learning Curve.

Protopapas A, Giannoulis G, Chatzipapas I, Athanasiou S, Grigoriadis T, Haidopoulos D, Loutradis D, Antsaklis A.

ISRN Obstet Gynecol. 2014 Jan 20;2014:853902. doi: 10.1155/2014/853902. eCollection 2014.

22.

Invasive diagnostic procedures and risk of hypertensive disorders in pregnancy.

Daskalakis G, Papapanagiotou A, Antonakopoulos N, Mesogitis S, Papantoniou N, Loutradis D, Antsaklis A.

Int J Gynaecol Obstet. 2014 May;125(2):146-9. doi: 10.1016/j.ijgo.2013.10.015. Epub 2014 Jan 21.

PMID:
24556088
23.

Comparative assessment of lymph node micrometastasis in cervical, endometrial and vulvar cancer: insights on the real time qRT-PCR approach versus immunohistochemistry, employing dual molecular markers.

Pappa KI, Rodolakis A, Christodoulou I, Gazouli M, Markaki S, Antsaklis A, Anagnou NP.

Biomed Res Int. 2014;2014:187684. doi: 10.1155/2014/187684. Epub 2014 Jan 2.

24.

Sentinel lymph node biopsy in uterine cervical cancer patients: ready for clinical use? A review of the literature.

Palla VV, Karaolanis G, Moris D, Antsaklis A.

ISRN Surg. 2014 Jan 16;2014:841618. doi: 10.1155/2014/841618. eCollection 2014. Review.

25.

Nodal, Nanog, DAZL and SMAD gene expression in human amniotic fluid stem cells.

Stefanidis K, Pergialiotis V, Christakis D, Loutradis D, Antsaklis A.

J Stem Cells. 2013;8(1):17-23.

PMID:
24459810
26.

Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study.

Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, Zografos GC, Ampela K, Mpaltas D, Papadimitriou C, Dimopoulos MA, Antsaklis A.

Breast Care (Basel). 2013 Jun;8(3):203-7. doi: 10.1159/000352093.

27.

Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.

Trohatou O, Zagoura D, Bitsika V, Pappa KI, Antsaklis A, Anagnou NP, Roubelakis MG.

Stem Cells Transl Med. 2014 Jan;3(1):54-68. doi: 10.5966/sctm.2013-0081. Epub 2013 Dec 4.

28.

Estimations of water balance after validating and administering the water balance questionnaire in pregnant women.

Malisova O, Protopappas A, Nyktari A, Bountziouka V, Antsaklis A, Zampelas A, Kapsokefalou M.

Int J Food Sci Nutr. 2014 May;65(3):280-5. doi: 10.3109/09637486.2013.860585. Epub 2013 Dec 3.

PMID:
24295329
29.

Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012-2013 influenza season.

Maltezou HC, Fotiou A, Antonakopoulos N, Kallogriopoulou C, Katerelos P, Dimopoulou A, Tsoutsa V, Siahanidou T, Papagaroufalis C, Kostis E, Papantoniou N, Antsaklis A, Theodoridou M.

Clin Infect Dis. 2013 Dec;57(11):1520-6. doi: 10.1093/cid/cit599. Epub 2013 Sep 17.

PMID:
24046313
30.

Does the presence of thyroid antibodies affect the course and outcome of pregnancy in type 1 diabetic women?

Sarantopoulou V, Vasileiou V, Sarika L, Philippou G, Alevizaki M, Antsaklis A, Anastasiou E.

J Perinat Med. 2014 Jan;42(1):69-74. doi: 10.1515/jpm-2012-0273.

PMID:
23985426
31.

Seven years of objective and subjective outcomes of transobturator (TVT-O) vaginal tape: why do tapes fail?

Athanasiou S, Grigoriadis T, Zacharakis D, Skampardonis N, Lourantou D, Antsaklis A.

Int Urogynecol J. 2014 Feb;25(2):219-25. doi: 10.1007/s00192-013-2186-8. Epub 2013 Jul 27.

PMID:
23892532
32.

Laparoscopically assisted vaginal radical hysterectomy: systematic review of the literature.

Pergialiotis V, Rodolakis A, Christakis D, Thomakos N, Vlachos G, Antsaklis A.

J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):745-53. doi: 10.1016/j.jmig.2013.04.021. Epub 2013 Jul 11. Review.

PMID:
23850361
33.

Breast cancer in women aged 25 years and younger.

Dimitrakakis C, Tsigginou A, Zagouri F, Marinopoulos S, Sergentanis TN, Keramopoulos A, Liakou P, Zografos GC, Papadimitriou CA, Dimopoulos MA, Antsaklis A.

Obstet Gynecol. 2013 Jun;121(6):1235-40. doi: 10.1097/AOG.0b013e318291ef9a.

PMID:
23812457
34.

Preterm birth rise in Greece: time for action.

Baroutis G, Mousiolis A, Mesogitis S, Costalos C, Antsaklis A.

Acta Obstet Gynecol Scand. 2013 Oct;92(10):1232. doi: 10.1111/aogs.12201. No abstract available.

PMID:
23782344
35.

Translation and psychometric evaluation of the Greek short forms of two condition-specific quality of life questionnaires for women with pelvic floor disorders: PFDI-20 and PFIQ-7.

Grigoriadis T, Athanasiou S, Giannoulis G, Mylona SC, Lourantou D, Antsaklis A.

Int Urogynecol J. 2013 Dec;24(12):2131-44. doi: 10.1007/s00192-013-2144-5. Epub 2013 Jun 19.

PMID:
23778998
36.

Maternal age demographic trends in Greece from 1980 to 2008.

Mousiolis A, Baroutis G, Papantoniou N, Costalos C, Antsaklis A.

J Reprod Med. 2013 May-Jun;58(5-6):246-55.

PMID:
23763011
37.

Trends in twin pregnancies and mode of delivery during the last 30 years: inconsistency between guidelines and clinical practice.

Antsaklis A, Malamas FM, Sindos M.

J Perinat Med. 2013 Jul;41(4):355-64. doi: 10.1515/jpm-2012-0175.

PMID:
23729533
38.

Induction of labor versus expectant management for pregnancies beyond 41 weeks.

Daskalakis G, Zacharakis D, Simou M, Pappa P, Detorakis S, Mesogitis S, Antsaklis A.

J Matern Fetal Neonatal Med. 2014 Jan;27(2):173-6. doi: 10.3109/14767058.2013.806892. Epub 2013 Jun 20.

PMID:
23682721
39.

MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.

Zagouri F, Sergentanis TN, Gazouli M, Dimitrakakis C, Tsigginou A, Papaspyrou I, Chrysikos D, Lymperi M, Zografos GC, Antsaklis A, Dimopoulos MA, Papadimitriou CA.

Mol Biol Rep. 2013 Aug;40(8):5035-40. doi: 10.1007/s11033-013-2604-5. Epub 2013 May 10.

PMID:
23661021
40.

Improved detection rate of structural abnormalities in the first trimester using an extended examination protocol.

Iliescu D, Tudorache S, Comanescu A, Antsaklis P, Cotarcea S, Novac L, Cernea N, Antsaklis A.

Ultrasound Obstet Gynecol. 2013 Sep;42(3):300-9. doi: 10.1002/uog.12489.

41.

RASSF1A in maternal plasma as a molecular marker of preeclampsia.

Papantoniou N, Bagiokos V, Agiannitopoulos K, Kolialexi A, Destouni A, Tounta G, Kanavakis E, Antsaklis A, Mavrou A.

Prenat Diagn. 2013 Jul;33(7):682-7. doi: 10.1002/pd.4093. Epub 2013 Mar 22.

PMID:
23526657
42.

Prenatal diagnosis of Wolf-Hirschhorn syndrome: ultrasonography and genetics.

Ikonomou T, Antsaklis P, Daskalakis G, Sindos M, Papantoniou N, Kosmaidou Z, Antsaklis A.

J Matern Fetal Neonatal Med. 2013 Jun;26(9):941-2. doi: 10.3109/14767058.2013.765855. Epub 2013 Feb 11. No abstract available.

PMID:
23398546
43.

Characterization of ovarian tumors and staging ovarian cancer with 3-dimensional power Doppler angiography: correlation with pathologic findings.

Kalmantis K, Rodolakis A, Daskalakis G, Antsaklis A.

Int J Gynecol Cancer. 2013 Mar;23(3):469-74. doi: 10.1097/IGC.0b013e3182866679.

PMID:
23360814
44.

Preterm birth trends in Greece, 1980-2008: a rising concern.

Baroutis G, Mousiolis A, Mesogitis S, Costalos C, Antsaklis A.

Acta Obstet Gynecol Scand. 2013 May;92(5):575-82. doi: 10.1111/aogs.12089. Epub 2013 Feb 28.

PMID:
23360152
45.

Circadian clock gene expression is impaired in gestational diabetes mellitus.

Pappa KI, Gazouli M, Anastasiou E, Iliodromiti Z, Antsaklis A, Anagnou NP.

Gynecol Endocrinol. 2013 Apr;29(4):331-5. doi: 10.3109/09513590.2012.743018. Epub 2013 Jan 17.

PMID:
23323702
46.

Appropriate cone dimensions to achieve negative excision margins after large loop excision of transformation zone in the uterine cervix for cervical intraepithelial neoplasia.

Papoutsis D, Rodolakis A, Mesogitis S, Sotiropoulou M, Antsaklis A.

Gynecol Obstet Invest. 2013;75(3):163-8. doi: 10.1159/000345864. Epub 2012 Dec 28.

PMID:
23296191
47.

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.

Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA.

Oncology. 2013;84(3):158-65. doi: 10.1159/000341366. Epub 2012 Dec 28.

PMID:
23296063
48.

Can isosorbide mononitrate be useful in second trimester termination of pregnancies?

Mousiolis A, Sindos M, Papantoniou N, Antsaklis A.

Contraception. 2013 Jul;88(1):41-4. doi: 10.1016/j.contraception.2012.11.018. Epub 2013 Jan 3.

PMID:
23290428
49.

Maternal age as a predictive factor of pre-term birth. An epidemiological study from 1999 to 2008 in Greece.

Mousiolis A, Baroutis G, Sindos M, Costalos C, Antsaklis A.

J Obstet Gynaecol. 2013 Jan;33(1):28-31. doi: 10.3109/01443615.2012.730078.

PMID:
23259874
50.

Detection of numerical abnormalities of chromosome 9 and p16/CDKN2A gene alterations in ovarian cancer with fish analysis.

Aravidis C, Panani AD, Kosmaidou Z, Thomakos N, Rodolakis A, Antsaklis A.

Anticancer Res. 2012 Dec;32(12):5309-13.

PMID:
23225431

Supplemental Content

Loading ...
Support Center